- Home
- PBM vs TTNP Comparison
PBM vs TTNP Comparison
Compare PBM & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- TTNP
- Stock Information
- Founded
- PBM 1994
- TTNP 1991
- Country
- PBM Canada
- TTNP United States
- Employees
- PBM N/A
- TTNP N/A
- Industry
- PBM
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBM
- TTNP Health Care
- Exchange
- PBM NYSE
- TTNP Nasdaq
- Market Cap
- PBM 4.0M
- TTNP 3.7M
- IPO Year
- PBM N/A
- TTNP 1996
- Fundamental
- Price
- PBM $0.05
- TTNP $3.81
- Analyst Decision
- PBM
- TTNP
- Analyst Count
- PBM 0
- TTNP 0
- Target Price
- PBM N/A
- TTNP N/A
- AVG Volume (30 Days)
- PBM 8.8M
- TTNP 8.5K
- Earning Date
- PBM 11-29-2024
- TTNP 11-29-2024
- Dividend Yield
- PBM N/A
- TTNP N/A
- EPS Growth
- PBM N/A
- TTNP N/A
- EPS
- PBM N/A
- TTNP N/A
- Revenue
- PBM N/A
- TTNP $3,000.00
- Revenue This Year
- PBM N/A
- TTNP N/A
- Revenue Next Year
- PBM N/A
- TTNP N/A
- P/E Ratio
- PBM N/A
- TTNP N/A
- Revenue Growth
- PBM N/A
- TTNP N/A
- 52 Week Low
- PBM $0.05
- TTNP $3.57
- 52 Week High
- PBM $14.55
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- PBM 27.59
- TTNP 34.23
- Support Level
- PBM $0.06
- TTNP $3.77
- Resistance Level
- PBM $0.06
- TTNP $4.66
- Average True Range (ATR)
- PBM 0.01
- TTNP 0.28
- MACD
- PBM 0.00
- TTNP 0.04
- Stochastic Oscillator
- PBM 1.07
- TTNP 3.93
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.